Effect of Nonsurgical Treatment on Salivary HGF Levels in Population with Periodontal Disease: A Quasi-experimental Study
- PMID: 33511065
- PMCID: PMC7801889
- DOI: 10.5005/jp-journals-10018-1320
Effect of Nonsurgical Treatment on Salivary HGF Levels in Population with Periodontal Disease: A Quasi-experimental Study
Abstract
Aim: To assess the effect of nonsurgical treatment on salivary hepatocyte growth factor (sHGF) levels in a population with periodontal disease: a quasi-experimental study.
Methods: Eighty-one patients (aged 30-70 years) were divided into three groups based on the gingival index, probing depth, clinical attachment loss, and radiographic evidence of bone loss: healthy (group I), gingivitis (group II), and chronic periodontitis (group III). Saliva samples were collected from these groups at baseline. At 8 weeks, saliva samples were collected again from group II and group III after the patients went through nonsurgical periodontal treatment. The levels of HGF were estimated using enzyme-linked immunosorbent assay (ELISA). The clinical parameters and HGF levels among all groups were analyzed using a one-way analysis of variance (ANOVA) using SPSS 17 version.
Results: At baseline, the highest mean HGF concentration in saliva was observed for group III (3455.83 ± 1463.44 pg/mL), and the least in group I (469.43 ± 317.13 pg/mL). Following nonsurgical periodontal treatment, the mean HGF concentration decreased significantly in group III and group II (p < 0.05). A significant positive correlation between clinical parameters and HGF levels was also seen (p < 0.05).
Conclusion: HGF concentration showed a positive correlation with the progression of periodontal disease.
Clinical significance: Following nonsurgical periodontal therapy, the levels of HGF decreased significantly, suggesting that HGF could be useful for monitoring the response to periodontal therapy.
How to cite this article: Alreja D, Rao JR, Kataria S, et al. Effect of Nonsurgical Treatment on Salivary HGF Levels in Population with Periodontal Disease: A Quasi-experimental Study. Euroasian J Hepato-Gastroenterol 2020;10(2):51-55.
Keywords: Biomarker; Boster's human HGF ELISA Kit®; Chronic periodontitis; Enzyme-linked immunosorbent assay; Gingivitis; Hepatocyte growth factor; Periodontal disease; Salivary hepatocyte growth factor.
Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.
Conflict of interest statement
Source of support: Nil Conflict of interest: None
Figures
References
-
- Ohshima M,, Noguchi Y,, Ito M,, Maeno M,, Otsuka K. Hepatocyte growth factor secreted by periodontal ligament and gingival fibroblasts is a major chemoattractant for gingival epithelial cells. J Periodontal Res. 2001;36:377–383. - PubMed
-
- Ohshima M,, Nishiyama T,, Yamazaki Y,, Yokosuka R,, Maeno M,, Otsuka K. Hepatocyte growth factor is a predominant chemoattractant for gingival epithelial cells produced by radicular cyst-derived fibroblast like cells. J Oral Sci. 2000;42:101–106. - PubMed
-
- Attstrom R,, Laural AB,, Lashsson V. Complement factors in gingival crevice material from healthy and inflamed gingiva in humans. J Periodontal Res. 1974;10:19–27. - PubMed
-
- Gherardi E,, Stoker M. Hepatocyte growth factor/scatter factor. Cancer Cells. 1991;3:227. - PubMed
LinkOut - more resources
Full Text Sources